NASDAQ:ARQT

Arcutis Biotherapeutics Earning Date

USA |NASDAQ |USD

ARQT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-1.13 $-0.84 $-1.01
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $0.00 $0.00 $0.00

Arcutis Biotherapeutics's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

ARQT Earnings Date & History Chart

ARQT Earnings & Revenue Forecast

ARQT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $-1.35 $-1.80 $-1.02
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $-4.25 $-4.93 $-3.63
Dec 2022 8 $-4.93 $-5.90 $-3.81

ARQT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.35 $-1.28 $-1.27
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-4.25 $-4.14 $-4.15
Dec 2022 1 / 0 $-4.93 $-4.92 $-4.95

ARQT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $0.00 $0.00 $0.00
Dec 2022 8 $7.91M $0.00 $32.56M

ARQT Earnings Date & Revenue History

ARQT Earnings History

|
Show More
Show More

ARQT Revenue History

|
Show More
Show More

Arcutis Biotherapeutics Next Earnings Date & Report

ARQT Next Earnings Date & Report Preview: Sep 2021 (FQ)

ARQT's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 7 analysts, the average EPS estimation for Arcutis Biotherapeutics's next quarterly earnings is $-1.13, with a low EPS estimation of $-1.53, and a high estimation of $-0.94.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-1.13, the last 2 month trend is $-1.06, and the 3 month trend is $-1.12.

Based on 3 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Arcutis Biotherapeutics Previous Earnings Dates & Reports

ARQT Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Arcutis Biotherapeutics's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

ARQT's earnings per share (EPS) was $-0.84, beating the consensus analysts forecast of $-0.93 by 9.36%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 10.53%, and higher than the same period a year before (Jun 2020) by -10.64%.

Revenues were $0.00.

The company reported a net income of $-42.01M.

Free cash flow for the quarter was $-35.87M , compared to $-46.76M last quarter and $-25.78M a year before.

ARQT ended the quarter with $5.14M in total debt, an increase of 1.74% compared to the previous quarter, and an increase of 39.24% compared to the same quarter a year before.

ARQT Previous Earnings Date & Report Recap: Dec 2020 (FY)

Arcutis Biotherapeutics's previous annual earnings date was Feb 16, 2021 for its fiscal year ended Dec 31, 2020.

ARQT's earnings per share (EPS) was $-3.89, beating the consensus analysts forecast of $-3.94 by -1.27% , and higher than the previous year's EPS (Dec 2019) by -36.54%.

Revenues were $0.00.

The company reported a net income of $-135.68M.

Arcutis Biotherapeutics reported a free cash flow of $-113.35M for its fiscal year, compared to $-43.13M a year ago.

The company ended the fiscal year with $4.96M in total debt, an increase of 1516.94% compared to the previous year.